-
Oil slides, stocks jump amid Iran-Israel ceasefire uncertainty
-
Ceasefire in Iran-Israel war takes hold
-
Former India spinner Dilip Doshi dies aged 77
-
Edwards appointed Middlesbrough manager
-
German budget plans outline vast spending - and record debt
-
Deadly dengue fever impacts climate-hit Bangladesh coast
-
France orders Tesla to end 'deceptive commercial practices'
-
France charges Briton over staged Disneyland 'marriage' with child
-
Israel says agreed to Trump plan for ceasefire with Iran
-
Brazil records 62% jump in area burned by forest fires: monitor
-
It will be 'big and punchy': Athletics chief Coe looks to future
-
India's Pant reprimanded for dissent in first Test
-
Oil prices drop as Israel agrees to ceasefire proposal
-
UK aims to tackle Google dominance of online search
-
'Not at the level': Atletico left to ruminate after Club World Cup KO
-
Border confusion as Thailand shuts land crossings with Cambodia
-
Vietnam puts 41 on trial in $45 mn corruption case
-
World facing 'most complex' situation in decades: WEF
-
Trial of Sean Combs approaches final stretch
-
Panama says has regained 'control' of restive province after months of protests
-
Trump says Iran-Israel ceasefire in force
-
Pharrell bigs up brown denim as Paris fashion week starts
-
'Companions' ease pain of China's bustling, bamboozling hospitals
-
Japan PM to face tough upper house election on July 20
-
Judge tells Australian mushroom murder jury to put emotion aside
-
Israel says 3 killed in Iran strike after Trump's ceasefire announcement
-
Messi's Miami and PSG progress to set up Club World Cup reunion
-
Rock on: how crushed stone could help fight climate change
-
Porto, Al Ahly out after sharing eight goals in thriller
-
Glamour, gripes as celebs head to Venice for exclusive Bezos wedding
-
Messi to face PSG after Miami and Palmeiras draw to go through
-
Schmidt warned he must release Wallabies for Lions warm-ups
-
Palmeiras fight back against Inter Miami - both teams through
-
With missiles overhead, Tel Aviv residents huddle underground
-
Virgin Australia surges in market comeback
-
Asian stocks up as Trump announces Iran-Israel ceasefire
-
Flatterer-in-chief: How NATO's Rutte worked to win over Trump
-
Iran signals halt to strikes if Israel stops
-
NATO summit seeks to keep Trump happy -- and alliance united
-
Russian drone attacks kill three in northeast Ukraine
-
Better than gold: how Ecuador cashed in on surging cocoa prices
-
Millions in US sweat out first extreme heat wave of year
-
Pro-Palestinian protest leader details 104 days spent in US custody
-
Gender not main factor in attacks on Egyptian woman pharaoh: study
-
'Throwing the book away' with no preparation for next season: Bayern's Kompany
-
XCF Global Announces Strategic International Expansion Framework to Accelerate Global SAF Adoption
-
ATHA Energy Discovers Mineralization Within the Angikuni Basin in First Hole at KU Target and Drilling at Lac 50 Deposit Extends Mineralization
-
Eskay Mining Announces Grant of Stock Options
-
Arrive AI Forges International Partnership, Bringing Secure Delivery to India with Skye Air Mobility
-
CBMJ's Patriot.TV and 220 Enterprises Ignite Equity Partnership to Power Expanded Next-Generation Media Platform
Featured
Last news

Wi2Wi Corporation Announces First Quarter 2025 Financial Results (Unaudited)
TORONTO, ON / ACCESS Newswire / May 16, 2025 / Wi2Wi Corporation (TSX-V:YTY)(OTC PINK:ISEYF) a leader in precision timing devices, frequency control products, and wireless technologies, today announced its financial results for the first quarter ended March 31, 2025.

CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
Cash expected to fund operations into the second half of 2026Advancing development strategy for lead program TPI 287 to commence Phase 2 study around year end 2025 for treatment of glioblastoma multiforme (GBM)

CASI Pharmaceuticals Announces First Quarter 2025 Business and Financial Results
BEIJING, CN / ACCESS Newswire / May 16, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the quarter ended March 31, 2025.

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu
SHELTON, CT / ACCESS Newswire / May 16, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending March 31, 2025 with the Securities and Exchange Commission (SEC) on Thursday, May 15, 2025. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/1379006/000141057825001336/nnvc-20250331x10q.htm) .

US cops investigating Smokey Robinson after sex assault lawsuit
Motown legend Smokey Robinson is under criminal investigation, law enforcement in Los Angeles said Thursday, just days after he was sued by four former housekeepers who allege the soul singer repeatedly raped and sexually assaulted them.

Real Madrid's Asencio wants 'presumption of innocence' in underage sex video case
Real Madrid defender Raul Asencio said Thursday a presumption of innocence "must continue to prevail" after he was indicted in a case involving the viewing and distribution of a sexual video involving a minor.
Cannes bars actor accused of rape in new #MeToo policy
The Cannes film festival barred an actor in a prominent French film from the red carpet on Thursday because of sexual assault allegations, unveiling a new policy under pressure from lawmakers and activists.

Slovenia probes disappearance of latest Melania Trump statue
The first Melania Trump statue in her native Slovenia was destroyed by fire and now its bronze replacement has gone missing, prompting a police investigation.

Rome businesses count their blessings with US pope
The election of the first US pope is a godsend to businesses in Rome, as big-spending pilgrims flocking to the Vatican are also expected to spend in the Eternal City.

'Unscientific' Japan megaquake rumours spook Hong Kong tourists
Unfounded online rumours warning that a huge earthquake will soon strike Japan are taking a toll on travel firms and airlines who report less demand from worried Hong Kongers.

South Korea police arrest two over Son Heung-min 'blackmail'
Two people have been arrested for allegedly blackmailing Spurs and South Korea captain Son Heung-min, police said Thursday.

Newsmax Announces First Quarter 2025 Financial Results
Company Reports Revenues of $45.3 million, an 11.6% Increase Year-Over-Year, In First Earnings Report as a Public CompanyNewsmax Remains the 4th Highest-Rated Cable News Channel With Over 33 Million Quarterly Viewers

WasteExpo 2025 Gathers more than 14,500 Registered Professionals to Unveil New Products and Solutions to Drive Efficiencies in Waste Management
This year's edition held 600+ exhibitors spanning 90 product categories, hosting critical conversations in technology & innovation, operations, fleet & safety, investment, upcycling and organics recycling.

Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth
ANN ARBOR, MI / ACCESS Newswire / May 15, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2025.

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
FORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2025 first quarter report on Form 10-Q on Thursday, May 15, 2025. The following are highlights of the report:

Envela Announces Dual Listing on NYSE Texas
IRVING, TX / ACCESS Newswire / May 15, 2025 / Envela Corporation today announced the dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas. The Company will maintain its primary listing on the NYSE American and will trade under the same ticker symbol, ELA, on NYSE Texas.

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results
- Therapeutic DNA Production Services Segment (LineaRx) Revenues Up 44% Y/Y, Contributing to a 6% Increase in Total Revenues -- Intra-Quarter Investor Conference Call and Webcast Scheduled for June 3, 2025, at 4:30 PM ET -

TruMerit Hails Release of WHO's State of the World's Nursing Report
The report highlights a critical imperative to strengthen global nursing capacity in the wake of the pandemic and amid economic uncertainty, climate change impacts, and persistent health inequities. It warns that the global health workforce shortage will continue to widen, reaching 11 million by 2030, thereby requiring a fundamental shift in how countries approach healthcare workforce planning and investment.

A1 Group announces Acquisition of New Production Facility
COLTON, CA / ACCESS Newswire / May 15, 2025 / A1 Group, Inc. (OTC:AWON -- hereinafter referred to as the "Company"), through its wholly-owned subsidiary, AICPG, LLC, stands as a pioneering force at the intersection of technology and consumer product development, today announced the acquisition of a fully integrated beverage manufacturing facility in Toronto, Canada.

Jaguar Health Reports First Quarter 2025 Financials
The combined net Q1 2025 revenue of approximately $2.2 million for prescription and non-prescription products, including license revenue, decreased approximately 6% versus net Q1 2024 revenue of $2.4 million and 37% versus net Q4 2024 revenue of $3.5 million Mytesi prescription volume increased by approximately 1.8% in Q1 2025 over Q1 2024 and decreased by approximately 13.5% in Q1 2025 over Q4 2024REMINDER: Today Jaguar to host investor webcast at 4:15 p.m. Eastern regarding Q1 2025 financials and company updates; Click here to registerProof-of-concept (POC) results show crofelemer reduced total parenteral nutrition in patients with rare orphan diseases microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) by up to 27% and 12.5% - potential to modify disease progression in intestinal failure patients; Click here to access replay of April 30, 2025 investor webcast about results; additional POC results expected throughout 2025 for MVID and SBS-IFFDA meeting in Q2 2025 on statistically significant results of Phase 3 OnTarget trial of crofelemer in prespecified subgroup of patients with breast cancer

AGS Health Expands into Mexico with Guadalajara Location Offering Clinical Administrative Services
WASHINGTON, DC / ACCESS Newswire / May 15, 2025 / AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., announced today its expansion into Mexico with the opening of an office in Guadalajara. Taking advantage of the region's growing technology presence and a skilled medical, legal, and engineering workforce, AGS Health will hire more than 150 team members to provide Clinical Administrative Services from the new location.

New to The Street(R) Signs Skip Barber Racing School to Upgraded 12-Part National Broadcast and Media Partnership
The Closest Thing to Royalty in American Car Racing

Interactive Strength Inc. (Nasdaq:TRNR) Shares Update from CEO Q&A Featuring Both TRNR and Sportstech CEO's
Top-to-Top Conversation Offers Transparency and ConfidenceAhead of Q1 Earnings Report

Telomir Pharmaceuticals Adds Telomir-Ag2 as a Novel Drug Candidate to Pipeline Following Breakthrough Efficacy Against MARSA and Drug-Resistant Infections, Targeting a $30B+ Antimicrobial Market Opportunity
Antimicrobial resistance is recognized as one of the top global public health threats, and Telomir-Ag2 strengthens Telomir's pipeline with a differentiated candidate designed to address this urgent and expanding crisis

Luvu Brands Announces Third Quarter Fiscal 2025 Results and Strategic Growth Initiatives
ATLANTA, GA / ACCESS Newswire / May 15, 2025 / Luvu Brands, Inc. (OTCQB:LUVU), a leading designer, manufacturer, and marketer of consumer lifestyle brands, today reported financial and operational results for the third quarter of fiscal 2025, ended March 31, 2025.

The Fresh Factory Reports Record Billed Revenue & EBITDA in Q1 2025
The Company reported its highest-ever quarterly billed revenue of $10.7M (CAD $15.2M) in Q1 2025, representing a year-over-year increase of 27% from Q1 2024.The Company achieved record positive EBITDA of $0.9M (CAD $1.2M) in Q1 2025, compared to $0.3M (CAD $0.4M) in Q1 2024.The Company completed the build-out of and started production at and shipping from its new Downers Grove facility.The Company expanded its capacity and improved the packaging capabilities of its new snack-bites line.

AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform
Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings.

Genflow Biosciences PLC Announces Key SIRT6 Patent Application
LONDON, UNITED KINGDOM / ACCESS Newswire / May 15, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, announces that the Japanese Patent Office has advanced its SIRT6-related patent application (Application No. JP 2024515284) to the national examination phase.

Relief Therapeutics Publishes 2025 Annual General Meeting Agenda
GENEVA, SWITZERLAND / ACCESS Newswire / May 15, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published the agenda for its 2025 Annual General Meeting (AGM) of shareholders, to be held on June 12, 2025, at 10:00 a.m. CEST in Geneva, Switzerland.

Mexican influencer shot dead during live stream
A Mexican social media influencer was shot dead during a live stream on TikTok, where she had tens of thousands of followers, authorities said Wednesday.

Crypto industry praises Trump, calls for market clarity
The start of President Donald Trump's term earned rave reviews at the world's leading crypto conference Wednesday, but top industry lawyers said digital platforms wanted regulatory clarity while the Republicans control Congress.

'Assassin's Creed' no saviour for struggling Ubisoft
A bumper release for the latest "Assassin's Creed" instalment did not save French video games giant Ubisoft from falling back into the red in its 2024-25 financial year, the company said on Wednesday.